Sulzer (SUN) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
23 Jun, 2025Executive summary
Order intake remained stable at CHF 1,020 million in Q1 2025, matching the previous year despite economic uncertainty.
Order backlog increased to CHF 2.5 billion, up CHF 0.2 billion from year-end 2024.
Financial highlights
Flow division order intake grew 4% year-over-year to CHF 398 million.
Services division order intake rose 8% year-over-year to CHF 392 million.
Chemtech division order intake declined 18% year-over-year to CHF 230 million, following large prior-year orders.
Outlook and guidance
Full-year 2025 guidance confirmed: organic order intake growth of 2% to 5%, sales growth of 5% to 8%.
EBITDA margin expected to exceed 15% of sales.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sulzer
- Record sales, profit, and margins support a higher dividend and positive 2026 outlook.SUN
Q4 202526 Feb 2026 - Order and sales growth drove higher profitability and upgraded 2024 guidance.SUN
H1 20242 Feb 2026 - Targets above-market growth, >17% EBITDA margin, and >22% ROCE by 2028, fully self-financed.SUN
CMD 20241 Feb 2026 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 202416 Dec 2025 - Order intake recovers, Services grow double digits, Chemtech hit by delays; guidance reaffirmed.SUN
Q3 2025 TU2 Nov 2025 - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 202524 Jul 2025 - Order intake up 9.2% year-over-year; full-year guidance and profitability targets reaffirmed.SUN
Q3 2024 TU13 Jun 2025